Apiam Animal Health Ltd (ASX: AHX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Apiam Animal Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $72.10 million
P/E Ratio 16.61
Dividend Yield 4.44%
Shares Outstanding 181.44 million
Earnings per share 0.027
Dividend per share 0.02
Year To Date Return 100.00%
Earnings Yield 6.02%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Apiam Animal Health Ltd (ASX: AHX)
    Latest News

    healthy pigs on the farm
    Share Market News

    Apiam (ASX:AHX) share price soars 12% on strong Q1 update

    The Apiam Animal Health Ltd (ASX: AHX) share price has jumped today following the release of a positive Q1 update.

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Thursday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Cheap Shares

    Are Telstra shares and these 2 ASX stocks too cheap to ignore?

    Are Telstra Corporation Ltd (ASX:TLS) shares and these 2 ASX stocks too cheap to ignore?

    Read more »

    a woman
    Share Market News

    Greencross share price rises after receiving court approval for the takeover

    The Greencross Limited (ASX:GXL) share price is up after receiving court approval for the takeover.

    Read more »

    a woman
    ⏸️ Diversification

    Buy these 3 ASX shares to instantly diversify your portfolio

    These 3 ASX shares can quickly diversify your portfolio very nicely.

    Read more »

    a woman
    Cheap Shares

    Are cheap value ASX shares about to create the best returns?

    Cheap value ASX shares could be the best ones to own.

    Read more »

    a woman
    Share Market News

    Here's why all insane valuations will eventually become sane one way or another

    Insane valuations will eventually become sane again.

    Read more »

    a woman
    Growth Shares

    Why I'm excited by these 2 ASX small caps

    I’m excited by these 2 small caps.

    Read more »

    a woman
    Share Market News

    5 things to watch on the ASX on Wednesday

    The shares of BHP Billiton Limited (ASX:BHP), Healthscope Ltd (ASX:HSO), and Oil Search Limited (ASX:OSH) will be on watch on…

    Read more »

    a woman
    ⏸️ Diversification

    Buy these 3 stocks to instantly diversify your portfolio

    These 3 shares will add good diversification for your portfolio.

    Read more »

    a woman
    Best Shares

    Why one top fund manager thinks these two "clobbered" vet stocks will rebound

    Writing in its July monthly update, the top performing Flinders Emerging Companies Fund said it is wary of strongly growing…

    Read more »

    a woman
    Share Market News

    Who else wants to diversify their portfolio?

    These 3 shares would be a good way of diversifying your portfolio.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    28 Aug 2024 $0.0100 100.00% Final 30 Sep 2024
    04 Mar 2024 $0.0100 100.00% Interim 03 Apr 2024
    21 Sep 2022 $0.0040 100.00% Final 21 Oct 2022
    21 Mar 2022 $0.0120 100.00% Interim 20 Apr 2022
    16 Sep 2021 $0.0120 100.00% Final 22 Oct 2021
    19 Mar 2021 $0.0120 100.00% Interim 23 Apr 2021
    17 Sep 2020 $0.0120 100.00% Final 23 Oct 2020
    20 Mar 2020 $0.0080 100.00% Interim 24 Apr 2020
    19 Sep 2019 $0.0080 100.00% Final 24 Oct 2019
    19 Mar 2019 $0.0080 100.00% Interim 24 Apr 2019
    19 Sep 2018 $0.0080 100.00% Final 26 Oct 2018
    13 Mar 2018 $0.0080 100.00% Interim 27 Apr 2018
    20 Sep 2017 $0.0000 100.00% Final 27 Oct 2017
    13 Mar 2017 $0.0080 100.00% Interim 27 Apr 2017

    AHX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Apiam Animal Health Ltd

    Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segmentsinclude Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed.

    AHX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Nov 2024 $0.42 $-0.04 -8.70% 642,567 $0.45 $0.45 $0.35
    20 Nov 2024 $0.46 $-0.01 -2.13% 49,360 $0.47 $0.47 $0.46
    19 Nov 2024 $0.47 $0.01 2.17% 15,408 $0.47 $0.47 $0.46
    18 Nov 2024 $0.46 $0.00 0.00% 33,373 $0.46 $0.48 $0.46
    15 Nov 2024 $0.46 $-0.04 -8.00% 194,262 $0.50 $0.50 $0.46
    14 Nov 2024 $0.50 $0.00 0.00% 45,376 $0.50 $0.50 $0.49
    13 Nov 2024 $0.50 $-0.01 -1.98% 15,508 $0.50 $0.51 $0.50
    12 Nov 2024 $0.51 $0.00 0.00% 30,617 $0.51 $0.51 $0.51
    11 Nov 2024 $0.51 $-0.01 -1.96% 299,997 $0.52 $0.52 $0.49
    08 Nov 2024 $0.51 $0.00 0.00% 5,000 $0.51 $0.51 $0.51
    07 Nov 2024 $0.51 $-0.02 -3.79% 71,538 $0.52 $0.52 $0.51
    06 Nov 2024 $0.53 $0.01 1.92% 2,193 $0.52 $0.53 $0.52
    05 Nov 2024 $0.52 $0.01 1.94% 20,056 $0.54 $0.54 $0.52
    04 Nov 2024 $0.52 $-0.01 -1.92% 58,762 $0.53 $0.54 $0.52
    01 Nov 2024 $0.52 $-0.01 -1.89% 63,825 $0.53 $0.54 $0.52
    31 Oct 2024 $0.53 $-0.01 -1.87% 47,757 $0.53 $0.55 $0.53
    30 Oct 2024 $0.54 $0.01 1.89% 81,590 $0.51 $0.54 $0.51
    29 Oct 2024 $0.53 $0.04 8.16% 167,785 $0.49 $0.55 $0.49
    28 Oct 2024 $0.49 $-0.03 -5.83% 170,001 $0.52 $0.52 $0.49
    25 Oct 2024 $0.52 $0.00 0.00% 49,897 $0.52 $0.53 $0.52
    24 Oct 2024 $0.52 $-0.01 -1.92% 45,885 $0.53 $0.53 $0.51
    23 Oct 2024 $0.52 $0.01 1.96% 23,996 $0.52 $0.53 $0.52

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2024 Christopher Richards Expiry 192,821 $102,195
    As advised by the company. 284,628 Performance Rights, lapsed
    30 Sep 2024 Christopher Richards Buy 873,864 $423,998
    Dividend Reinvestment Plan (DRP).
    30 Sep 2024 Jan Tennent Buy 2,591 $1,257
    Dividend Reinvestment Plan (DRP).
    30 Sep 2024 Andrew Vizard Buy 7,134 $3,461
    Dividend Reinvestment Plan (DRP).
    30 Sep 2024 Richard (Rick) Dennis Buy 256 $124
    Dividend Reinvestment Plan (DRP).
    31 May 2024 Christopher Richards Buy 311,715 $106,668
    Off-market trade. As per announcement on 04-06-2024
    30 May 2024 Christopher Richards Buy 38,209 $13,885
    On-market trade.
    03 Apr 2024 Andrew Vizard Buy 10,075 $3,361
    Dividend Reinvestment Plan (DRP).
    03 Apr 2024 Christopher Richards Buy 1,174,271 $391,736
    Dividend Reinvestment Plan (DRP).
    03 Apr 2024 Richard (Rick) Dennis Buy 361 $120
    Dividend Reinvestment Plan (DRP).
    03 Apr 2024 Jan Tennent Buy 3,659 $1,220
    Dividend Reinvestment Plan (DRP).
    28 Mar 2024 Christopher Richards Buy 1,701,996 $595,698
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Professor Andrew Lancelot Vizard Non-Executive ChairmanNon-Executive Director Nov 2015
    Professor Vizard is a Principal Fellow at the Faculty of Veterinary and Agricultural Sciences, University of Melbourne and previously Associate Professor of Veterinary Epidemiology and Director of The Mackinnon Project, a recognized leader in sheep and beef veterinary consultancy. An experienced company director, he has previously held directorships in ASX companies, statutory bodies and research organizations including Animal Health Australia, the body responsible for coordinating Australia's animal health system; Primesafe, the statutory authority responsible for regulating the production of safe meat in Victoria. He is currently Chair of the Vizard Foundation and Executive Secretary for the Hermon Slade Foundation and the Australia & Pacific Science Foundation.
    Mr Bruce Robert Dixon Non-Executive Director Oct 2024
    Mr Dixon has over 30 years of management, commercial and Board experience including as Nonexecutive Director of Greencross Limited (one of Australias largest veterinary and pet care providers) and Ruralco Limited (Australian agribusiness). Mr Dixon was also the founder and Chair of Australian Venue Co, where following its sale to KKR in 2017, he remained on the AVC Board and as a shareholder until its sale earlier this year to PAG Asia Capital. Mr Dixon also previously held the position of Chief Executive Officer of Spotless Group Holdings Ltd and Healthscope Limited. Mr Dixon is currently Executive Director of Linen Services Australia (formally Spotless Linen) as well as a Director of a number of private companies.
    Mr Richard (Rick) John Dennis Non-Executive Director Nov 2015
    Mr Dennis held several senior roles for over 35 years with Ernst & Young (EY) and was the Managing Partner of EYs Queensland practice on two occasions from 2001-2007 and from 2014-15. Rick also held several executive management roles at EY, including Deputy COO and CFO for the Asia-Pacific practice where he was responsible for overseeing the financial and operational integration of EYs Australian and Asian member firms. Rick is a member of Australian Super's Queensland Advisory Board, a member of the Advisory Boards of EWM Group and HLB Chessboard, and an external member of the Audit & Risk Committee of Racing Queensland.
    Ms Evonne Maree Collier Non-Executive Director Oct 2022
    Ms Collier is an experienced leader combining current board (ASX, private, publicly unlisted) and governance experience with a successful career in Executive Director level Marketing, Innovation/Technology and Commercial roles managing large profit or loss and balance sheets across diverse industries in blue-chip, multi-national organizations. She has a track record in bringing high growth strategic direction to organizations including commercializing transformative, new to world products and services and an expert background in driving brand profile, customer experience/journeying and growing market share and sales across channels, including digital products/services.
    Dr Christopher Irwin Richards Managing Director Mar 2015
    Dr Richards is the Managing Director of Australian subsidiary entities and joint venture companies, which provide veterinary services to Australian regional and rural communities. Chris is responsible for the strategic direction of Apiam, which has seen the develop, grow, acquire and integrate production and companion animal veterinary clinics, veterinary wholesale, logistics, laboratory and genetics services businesses since 1998 into the Apiam of today Chris is also a director of registered charity, Fur Life Foundation Ltd, which raises funds to support people in rural, regional, and remote communities
    Professor Jan Tennent Non-Executive Director Aug 2018
    Professor Tennent is an internationally recognized researcher with specialist knowledge of antimicrobial resistance mechanisms and the discovery and commercialization of vaccines. Jan has held senior roles at CSIRO, the CRC for Vaccine Technology, CSL, and Pfizer Animal Health (now Zoetis) where she was the Director of Business Development and Global Alliances in the APAC region. Her most recent executive role was as CEO of Biomedical Research Victoria (2012-2019). Jan is also a non-executive director of Agriculture Victoria Services Pty Ltd, Phytogene Pty Ltd, AusBiotech Limited and eviDent Foundation Limited.
    Ms Eryl Baron Company Secretary Nov 2020
    -
    Matthew White Chief Financial Officer
    -
    Renee Waters Chief People Officer
    -
    Duncan Runciman Chief Veterinary Officer
    -
    Eryl Baron Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Cjoea Family Company Pty Ltd <Richards Family A/C> 36,661,071 20.21%
    Petstock Investments Pty Ltd 21,240,500 11.71%
    UBS Nominees Pty Ltd 10,947,749 6.03%
    Citicorp Nominees Pty Limited 8,228,248 4.53%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 3,363,296 1.85%
    3Fj Pty Ltd <Fojo Super Fund A/C> 3,138,174 1.73%
    Mr Brian Scutt 2,728,822 1.50%
    HSBC Custody Nominees (Australia) Limited 2,682,139 1.48%
    Cjoea Family Company Pty Ltd <Richards Family A/C> i 2,655,767 1.46%
    J P Morgan Nominees Australia Pty Limited 1,977,759 1.09%
    Cobash Pty Limited <J & S Wright Family A/C> 1,872,006 1.03%
    Mr Roger Charles Carmody & Mrs Maris Moore Carmody <Sandridge S/F A/C> 1,742,791 0.96%
    Jinland Pty Ltd <Jinland Family A/C> 1,740,000 0.96%
    Orem Holdings Pty Ltd 1,669,306 0.92%
    Hamilton Animal Health Pty Ltd 1,564,270 0.86%
    Certane Ct Pty Ltd <Apiam Animal Est Unallo Ac> 1,484,009 0.82%
    Fergus Macbeth Hay 1,446,946 0.80%
    Four Post Investments Pty Ltd <Johnstone Investment A/C> 1,386,700 0.76%
    Mrs Rachel Louise O'Meara 1,377,888 0.76%
    Michael James Whiteford 1,347,657 0.74%
    Sarah Leonnie Jalim 1,347,657 0.76%
    Simon James Robinson 1,347,657 0.74%

    Profile

    since

    Note